TOPIC DISCUSSION: MEMS and ESRD

The NYHA heart failure patients have a new device that is useful in predicting their volume status. A Lancet article in 2013 showed that this device called the CARDIOMEMS ( implantable hemodynamic monitoring).  This big study showed that it reduced hospitalizations of heart failure patients.  This device measures the pulmonary artery pressures (PAP) via remote monitoring.  The device is placed via interventional means and the remote box predicts the PAP. Based on that the physician can assess volume status and increase or decrease diuretics or give fluids preventing inpatient visits. 

The holy grail of ESRD patients has been the dry weight and how do we know they are more volume overloaded or need more UF.   MEMS or microelectromechanical systems can perhaps play a major role in renal care.  MEMS offers a potential to predict volume status in ESRD patients.  The current use of drt weight comes with fluctuations, errors and not much reliability.  This device could be planted in HD patients and perhaps we could remotely monitor their fluid status and call for extra UF sessions, or remove less fluid and so forth and perhaps even prevent hospitalizations.  

Kim and Ray summarize the use of potential of MEMs in the nephrology world.

What an amazing achievement by the cardiologists.

Onconephrology CME: Sept 26th one day symposium: First of it's kind

One last push for a plug in for the first ever one day CME on onconephrology.  It's ASN, ISN, NKF and C-KIN endorsed event.  

We are conducting a one day symposium on OncoNephrology: Cancer, chemotherapy and the Kidney at Hofstra NSLIJ School of Medicine on Sept 26th, 2015 from 7:30AM to 4PM
The conference will highlight and review the latest happenings in OncoNephrology

WHY to attend:

1. First of it's kind in USA to focus on this topic
2. We shall be using innovative technology to allow for a fun and interactive conference( polleverywhere, joinme and so forth)
3. A chance to win few nephrology textbooks as a raffle during the day
4. FREE to attend for any trainee ( student, fellows or residents)
5. Live tweeting of conference will be available via AJKDblog


Talks and Speakers highlighted;

AKI in Cancer Patients;  Joseph Bonventre, Harvard Medical School
Chemotherapy Toxicities:  Mark Perazella, Yale University
Targeted Therapy and the Kidney: Kenar Jhaveri, Hofstra University
Hypercalcemia of Malignancy: Naveed Masani, Winthrop University
Anemia, CKD, ESKD and cancer: Steven Fishbane, Hofstra University
Renal Cancer, an update: Thomas Bradley, Hofstra University, NSLIJ Cancer Institute
Paraneoplastic GN; Hitesh H Shah, Hofstra University
TMA:  Bradley Dixon, Cincinnati Children Hospital
Post Kidney Transplant Cancers: Vinay Nair, Mt Sinai Medical Center
Paraproteinemias, an update: Gerald Appel, Columbia University Medical Center
Cases with the Onconephropathologist: Glen Markowitz, Columbia Medical Center

Course directors:  Kenar Jhaveri, Steven Fishbane and Thomas Bradley( Division of Nephrology and Hematology/Oncology at Hofstra NSLIJ School of Medicine)
Planning committee: Kenar Jhaveri, Steven Fishbane and Thomas Bradley, Hitesh H Shah, Pravin Singhal, Jyotsana Thakkar and Rimda Wanchoo( all from Division of Nephrology, Hofstra NSLIJ School of Medicine)

To Register: go here

TOPIC DISCUSSION: Mnemonic for toxins that are removed by hemodialysis

Toxins that are removed by hemodialysis

Here is a mnemonic I found online

I   STUMBLE

I = Isopropanol
S= Salicylates
T = Theophyline
U = Uremia
M= Methanol
B= Barbituates, beta blockers (water soluble ones such as atenolol)
L= Lithium
E= Ethylene glycol

Source: http://crashingpatient.com/toxicology/general-toxicology-random-drugs.htm/